A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
Clinical trial NCT03922477 · TERMINATED
Trial details
- NCT number
- NCT03922477
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-08
- Primary completion
- 2020-11-03
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.